Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2003, p. 5288-5290, Vol. 41, No. 11
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.11.5288-5290.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Obstetrics and Gynecology, Faculty of Medicine, Khon Kaen University, Khon Kaen,1 Department of Obstetrics and Gynecology, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand,2 Department of Clinical Epidemiology, University of the Philippines, Manila, The Philippines,3 Coombe Women's Hospital, Dublin, Ireland,4 Respiratory Diseases Branch,5 Biostatistics and Information Management Branch, Division of Bacterial and Mycotic Diseases, National Centers for Infectious Diseases, Centers for Disease ControlPrevention, Atlanta, Georgia,6 Department of Obstetrics and Gynaecology, University of Zimbabwe School of Medicine, Harare, Zimbabwe,7 Department of Obstetrics and Gynaecology, Institute of Medicine, Yangon, Myanmar,8 Department of Obstetrics and Gynecology, Divisions of Research in Reproductive Health and Maternal-Fetal Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania9
Received 28 February 2003/ Returned for modification 16 April 2003/ Accepted 27 August 2003
|
|
|---|
|
|
|---|
We conducted the study at institutions participating in the Global Network for Perinatal and Reproductive Health (http://www.tju.edu/obgyn/rih/global.cfm). Centers were located in Khon Kaen and Bangkok, Thailand; Manila, The Philippines; Harare, Zimbabwe; Yangon, Myanmar; Dublin, Ireland; and Philadelphia, Pennsylvania. Participants were enrolled in the study between June 1999 and May 2001. Women attending prenatal care clinics and at 20 to 32 weeks gestation were eligible. Exclusion criteria included vaginitis symptoms, fever, vaginal bleeding, multiple pregnancy, use of antibiotics in the past 2 weeks, and active labor. Informed consent was obtained. The study was approved by institutional review boards at all study centers and supporting institutions.
At enrollment, study personnel conducted an interview and collected specimens. A sample for GBS rapid testing was collected from the cervix and lower vagina using a ThermoBiostar swab. OIAs were read by study site laboratory personnel and by the manufacturer's laboratory personnel. OIA kits and swabs were supplied by ThermoBiostar.
Methods for GBS culture and quantitation replicated those used in the Vaginal Infections and Prematurity Study (16). After collection of the OIA specimen, a Dacron swab (Copan swab) was used to collect a specimen from the cervix and lower vagina. Samples were streaked onto blood agar plates using the four-quadrant method and then placed into Lim broth (Todd-Hewitt broth containing selective antimicrobial agents). A clean catch urine specimen was collected for GBS culture on blood agar. Suspect colonies showing ß-hemolysis were identified as GBS using latex agglutination. Heavy colonization was defined as isolation of GBS from either urine or direct plating on blood agar. Light colonization was defined as isolation of GBS from Lim broth alone. Dense GBS colonization was defined as growth in the third or fourth quadrant streaked on the blood agar plate (14).
Data were entered by using Epi-Info version 6 (9) and transmitted to the Centers for Disease Control and Prevention monthly. We calculated the sensitivity, specificity, positive predictive value, and negative predictive value of the OIA using culture results as the "gold standard." The chi-square test was used to compare the results of OIA readings done by the manufacturer's staff versus the readings done by study center personnel.
We enrolled 1,306 women; their mean age was 26.6 years, and the mean gestational age was 26.3 weeks. GBS colonization was the highest in Philadelphia, Pa., (22.1%) and lowest in Yangon, Myanmar (7.1%). The rate of GBS isolation was higher from Lim broth culture than from other methods (Table 1).
|
View this table: [in a new window] |
TABLE 1. Prevalence of GBS according to various culture methods and OIA by study center
|
|
View this table: [in a new window] |
TABLE 2. Diagnostic performance of OIA for detection of vaginal carriage of GBS compared to culture in women with light, heavy, and dense GBS colonization (n = 1,306)
|
In previous studies, the performance of the OIA has been compared with selective broth media. The specificity was uniformly high, 85 to 98%, similar to the 98.4% in our study. Conversely, previously reported test sensitivities varied widely but were generally higher (37 to 81%) (2, 5, 7, 12-14, 17-19) than the value we found (26.8%). The most important reason for this variability may be the extent to which the subjects were colonized. The sensitivity of the OIA has been higher (61 to 100%) when compared with third- and fourth-quadrant positive blood agar cultures (2, 5, 7, 12-14). Our finding was within this range (68.4%).
Our study had limitations, as it did not evaluate the performance of the OIA 4 to 5 weeks before delivery or at delivery, when it would have the most clinical value (8). However, the average gestational age for our participants was 26.3 weeks, a time when the fetus is considered viable in many centers, making our data potentially useful for evaluating the role of GBS in preterm birth. We did not collect specimens from the rectum; collecting both rectal and vaginal cultures increases the detection of GBS carriage in pregnant women (1). If we had collected rectal specimens, we would have identified more GBS carriers, and the OIA performance would have been worse.
In conclusion, the low sensitivity of the Strep B OIA may limit its usefulness for detecting GBS in pregnant women, although the best performance of the test is in women who are heavily colonized and who therefore may be at highest risk for complications due to GBS infection. New tests, such as the newly licensed PCR test, may provide other options (4). For now, culture of specimens from the rectum and lower vagina remain the gold standard for detecting GBS colonization in pregnant women (8).
We thank the Rockefeller Foundation; the Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases; the Prevention Committee and the Office of Minority and Women's Health, Centers for Disease Control and Prevention, Atlanta, Ga.; USAID; INCLEN; and Thomas Jefferson University for technical support on this project. In addition, we thank ThermoBiostar, Inc., for supplying the OIA kits and for technical support for this study.
J. Thinkhamrop, S. Limpongsanurak, M. Festin, S. Daly, A. Schuchat, P. Lumbiganon, E. Zell, T. Chipato, A. A. Win, M. J. Perilla, J. E. Tolosa, and C. G. Whitney are members of the Global Network for Perinatal and Reproductive Health (GNPRH), Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, Pa.. GNPRH study centers and coinvestigators follow: Khon Kaen University (Khon Kaen, Thailand), Unchalee Tatttawasart, Kaewjai Khamsuk, and Ladda Sriboonreung; Chulalongkorn University (Bangkok, Thailand), Sompop Limpongsanurak, Surasith Chaithonhgwattana, Pongpun Nunthapisud, Sumanee Nin-gate, and Wanwadee Sripitak; Coombe Women's Hospital (Dublin, Ireland), Amanda Cotter, Julie Grantham, and James Fagan; Institute of Medicine, Women's Central Hospital (Yangon, Myanmar), Kyi Kyi Thinn, Win Win Maw, Cho Cho Oo, MarLar Win, Thuzar Han, Mya Mya Aye, Tin Ohn Myat, and Katherine Ba-Thike; University of Zimbabwe (Harare, Zimbabwe), Alexio Mashu, Laina Chidede, Marshall Munjoma, Travor Nyamurera, and Evelyn Mudzviti; University of the Philippines (Manila, The Philippines), Guadalupe N. Villanueva, Maybelle Cagayan, Concepcion Ang, Francis Sarmiento, Daniel Morales, and Celeridad Padrinao; Population Council (Bangkok, Thailand), Josephine Sauvarin, Christopher Elias, and Washiraporn Suramaythangkoon; Centers for Disease Control and Prevention, Falgunee Parekh, Carolyn Wright, Richard Facklam, and John Elliott; Department of Obstetrics and Gynecology, University of Alabama at Birmingham, William Andrews, Martha Lyon, Sue Cliver, and Robert Goldenberg; Thomas Jefferson University, Catherine Farrell, Babu Cheku, Tracey James, Letitia Lee, Michelle Di Vito, Michelle Pollino, Donald Jungkind, Jim Bondi, Vincenzo Berghella, Jay Goldberg, Ratana Komwilaisak, and Jennifer Culhane.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»